Post infectious glomerulonephritis
This is an online E log book to discuss our patient's de-identified health data shared after taking his/her/guardian's signed informed consent.
Here we discuss our individual patient's problems through series of inputs from available global online community of experts with an aim to solve those patient's clinical problems with collective current best evidence based inputs.
This E log book also reflects my patient-centered online learning portfolio and your valuable inputs on the comment box is welcome.
Here is a case i have seen:
65 yr old male patient ,Farmer by occupation ,who was apparently asymptomatic 3 months ( August) back then he developed B/L lower limb ulcerative lesions for 5days,lower limb swelling , decreased urine output, hematuria and vomiting for 2 days.So he went to a hospital in Hyderabad, then did some investigations below.
Renal biopsy was done on 18/08/20 under local anaesthesia
His autoimmune profile showed c3-low,c4There he underwent hemodialysis thrice a week for 2 months(Total 24 dialysis)
Last month he went to a hospital in nalgonda for dialysis there 14 dialysis were done for a month.
Now he came to hospital on 27/10/20 with
complaints of pedal edema since 3 days
Complaints of decreased urine output since 2 days
Pedal edema ,which was gradually progressive, pitting type,aggregated on work .
No history of burning micturition
No history of jaundice
No history of sob
PAST HISTORY:
Not a k/c/o HTN,DM,TB,asthma, epilepsy,CVA.
FAMILY HISTORY:
No significant family history.
DRUG HISTORY: H/O NSAID usage once or twice a month.
PERSONAL HISTORY:
No H/O significant alcohol intake,smoking.
O/E :
Pallor +
Icterus -
Cynosis -
Clubbing -
edema -
Patient is C/C/C
VITALS: TEMP: AFEBRILE ON TOUCH
BP:140/90MMHG
PR:98bpm
RR:22 cpm
SPO2:97%
INVESTIGATIONS:
Dialysis was done on 1/11/20
1. T.NICARDIA 10mg/po/TID
2. INJ.LASIX 40mg/IV/BD
3. T.NODOSIS 500mg /po/BD
4. T.SHELCAL 500mg/po/OD
5. T.OROFER XT /po/BD
6. T.PAN 40mg/po/OD
7. T.ALPHA D3/po/OD
#c3#h8#a1#n#d4#r#i9#a1#h8#
Comments
Post a Comment